99 related articles for article (PubMed ID: 12930936)
1. Nitroprusside in critically ill patients with aortic stenosis.
Agarwal PK; Kumari R
N Engl J Med; 2003 Aug; 349(8):811-3; author reply 811-3. PubMed ID: 12930936
[No Abstract] [Full Text] [Related]
2. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.
Khot UN; Novaro GM; Popović ZB; Mills RM; Thomas JD; Tuzcu EM; Hammer D; Nissen SE; Francis GS
N Engl J Med; 2003 May; 348(18):1756-63. PubMed ID: 12724481
[TBL] [Abstract][Full Text] [Related]
3. Nitroprusside in critically ill patients with aortic stenosis.
Gogbashian A
N Engl J Med; 2003 Aug; 349(8):811-3; author reply 811-3. PubMed ID: 12931716
[No Abstract] [Full Text] [Related]
4. Nitroprusside in critically ill patients with aortic stenosis.
Karthikeyan G
N Engl J Med; 2003 Aug; 349(8):811-3; author reply 811-3. PubMed ID: 12931715
[No Abstract] [Full Text] [Related]
5. Sodium-nitroprusside-induced cyanide toxicity in pediatric patients.
Thomas C; Svehla L; Moffett BS
Expert Opin Drug Saf; 2009 Sep; 8(5):599-602. PubMed ID: 19645589
[TBL] [Abstract][Full Text] [Related]
6. Thiocyanate Accumulation in Critically Ill Patients Receiving Nitroprusside Infusions.
Morris AA; Page RL; Baumgartner LJ; Mueller SW; MacLaren R; Fish DN; Kiser TH
J Intensive Care Med; 2017 Oct; 32(9):547-553. PubMed ID: 27435907
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of sodium nitroprusside.
Dwyer MM; Morris CL
Conn Med; 1993 Jul; 57(7):489-92. PubMed ID: 8403888
[No Abstract] [Full Text] [Related]
8. [Effects of sodium nitroprusside and its metabolites on erythrocyte function. Study in humans].
du Cailar J; Mathieu-Daude JC; Deschodt J; Lamarche Y; Castel J
Ann Anesthesiol Fr; 1977; 18(10):811-21. PubMed ID: 23022
[No Abstract] [Full Text] [Related]
9. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction.
Eleid MF; Nishimura RA; Sorajja P; Borlaug BA
Circulation; 2013 Sep; 128(12):1349-53. PubMed ID: 23956211
[TBL] [Abstract][Full Text] [Related]
10. Prolonged high-dose administration of sodium nitroprusside in the intensive care unit.
Mandragos C; Sarantopoulos C; Amygdalou A; Behrakis PK
Intensive Care Med; 1998 Aug; 24(8):889. PubMed ID: 9757937
[No Abstract] [Full Text] [Related]
11. The cardiovascular safety of sodium nitroprusside in acute heart failure.
Bocchino PP; Angelini F; Gallone G; Frea S; De Ferrari GM
Expert Opin Drug Saf; 2024 Jun; 23(6):663-666. PubMed ID: 38661629
[No Abstract] [Full Text] [Related]
12. Hemodynamic effects of nitroprusside on valvular aortic stenosis.
Zion MM
Am J Cardiol; 1992 Dec; 70(20):1639-40. PubMed ID: 1466349
[No Abstract] [Full Text] [Related]
13. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
García-González MJ; Jorge-Pérez P; Jiménez-Sosa A; Acea AB; Lacalzada Almeida JB; Ferrer Hita JJ
Cardiovasc Ther; 2015 Aug; 33(4):193-9. PubMed ID: 25959786
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of sodium nitroprusside use and assessment of the potential risk of cyanide poisoning.
Johanning RJ; Zaske DE; Tschida SJ; Johnson SV; Hoey LL; Vance-Bryan K
Pharmacotherapy; 1995; 15(6):773-7. PubMed ID: 8602386
[TBL] [Abstract][Full Text] [Related]
15. Delayed presentation of nitroprusside-induced cyanide toxicity.
Udeh CI; Ting M; Arango M; Mick S
Ann Thorac Surg; 2015 Apr; 99(4):1432-4. PubMed ID: 25841829
[TBL] [Abstract][Full Text] [Related]
16. Comparison of combination therapy of adenosine and nitroprusside with adenosine[correction for adensosine] alone in the treatment of angiographic no-reflow phenomenon: does 1 plus 1 equal 11?
Bailey SR
Catheter Cardiovasc Interv; 2004 Apr; 61(4):492-3. PubMed ID: 15065144
[No Abstract] [Full Text] [Related]
17. Comparison of fractional flow reserve measurements using intracoronary adenosine versus intracoronary sodium nitroprusside infusions in moderately stenotic coronary artery lesions.
Safi M; Namazi MH; Fooladi E; Vakili H; Parsa SA; Khaheshi I; Abbasi MA; Movahed MR
Cardiovasc Revasc Med; 2016; 17(7):441-443. PubMed ID: 27432209
[TBL] [Abstract][Full Text] [Related]
18. Monitoring cyanide and thiocyanate concentrations during infusion of sodium nitroprusside in children.
Linakis JG; Lacouture PG; Woolf A
Pediatr Cardiol; 1991 Oct; 12(4):214-8. PubMed ID: 1946009
[TBL] [Abstract][Full Text] [Related]
19. Successful administration of levosimendan in a patient with low-gradient low-output aortic stenosis.
Hoefer D; Jonetzko P; Hoermann C; Laufer G; Poelzl G
Wien Klin Wochenschr; 2006 Feb; 118(1-2):60-2. PubMed ID: 16489528
[TBL] [Abstract][Full Text] [Related]
20. Aortic stenosis and angiotensin-converting enzyme inhibitors--rupture of an ancient paradigm?
Barrera-Ramírez CF; Pineda-Pompa LR; Ilarraza H
Am Heart J; 2005 Feb; 149(2):E5; author reply E7. PubMed ID: 15846247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
